Ctt Pharmaceutical Holdings Stock Market Value
| CTTH Stock | USD 0.06 0.02 22.37% |
| Symbol | CTT |
CTT Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CTT Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CTT Pharmaceutical.
| 02/01/2025 |
| 03/03/2025 |
If you would invest 0.00 in CTT Pharmaceutical on February 1, 2025 and sell it all today you would earn a total of 0.00 from holding CTT Pharmaceutical Holdings or generate 0.0% return on investment in CTT Pharmaceutical over 30 days. CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treat... More
CTT Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CTT Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CTT Pharmaceutical Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.28 | |||
| Information Ratio | 0.0684 | |||
| Maximum Drawdown | 109.15 | |||
| Value At Risk | (18.28) | |||
| Potential Upside | 26.79 |
CTT Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CTT Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CTT Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use CTT Pharmaceutical historical prices to predict the future CTT Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0594 | |||
| Jensen Alpha | 1.29 | |||
| Total Risk Alpha | 1.77 | |||
| Sortino Ratio | 0.109 | |||
| Treynor Ratio | 0.3275 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CTT Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CTT Pharmaceutical Backtested Returns
CTT Pharmaceutical is out of control given 3 months investment horizon. CTT Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0635, which signifies that the company had a 0.0635 % return per unit of volatility over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.18% are justified by taking the suggested risk. Use CTT Pharmaceutical mean deviation of 9.92, and Risk Adjusted Performance of 0.0594 to evaluate company specific risk that cannot be diversified away. CTT Pharmaceutical holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.68, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CTT Pharmaceutical will likely underperform. Use CTT Pharmaceutical value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on CTT Pharmaceutical.
Auto-correlation | -0.04 |
Very weak reverse predictability
CTT Pharmaceutical Holdings has very weak reverse predictability. Overlapping area represents the amount of predictability between CTT Pharmaceutical time series from 1st of February 2025 to 16th of February 2025 and 16th of February 2025 to 3rd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CTT Pharmaceutical price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current CTT Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
CTT Pharmaceutical lagged returns against current returns
Autocorrelation, which is CTT Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CTT Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of CTT Pharmaceutical returns to help us make a trade decision. For example, suppose you find that CTT Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CTT Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CTT Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CTT Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CTT Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
CTT Pharmaceutical Lagged Returns
When evaluating CTT Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CTT Pharmaceutical pink sheet have on its future price. CTT Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CTT Pharmaceutical autocorrelation shows the relationship between CTT Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CTT Pharmaceutical Holdings.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in CTT Pink Sheet
CTT Pharmaceutical financial ratios help investors to determine whether CTT Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CTT with respect to the benefits of owning CTT Pharmaceutical security.